Skip to content

Lexeo Therapeutics

Scientist II, Cellular Neuroscience and Translational Pharmacology

Compensation
$127K–$150K / yr
Location
New York, NY, US
Arrangement
On-site
Employment type
Full-time
Posted
13 October 2026 (about a month ago)

Checked 20 days agoApplications go to the employer, never to RoleSprint

About this role

Role Summary We are seeking a highly collaborative, hands-on Scientist II to help establish a preclinical neuroscience laboratory supporting small-molecule and protein therapeutics. The immediate priorities are rapid cellular profiling and lead selection for an advanced small-molecule enzyme program, and leadership of cellular development for a transferrin-based protein replacement project. The role will also build fit-for-purpose human neuronal models, laboratory workflows, and external partnerships. Location We welcome applications from candidates located across the Northeast and Mid-Atlantic.

Primary Responsibilities • Lead a rapid, tiered cellular assay strategy for small-molecule lead optimization, including target engagement, pharmacodynamics, concentration-response, duration, selectivity, neuronal phenotype, stress, and tolerability

• Lead cellular development of a transferrin-based protein replacement project by establishing quantitative assays for construct uptake, internalization, intracellular trafficking, protein abundance and integrity, mitochondrial response, and disease-relevant phenotypic rescue

• Use orthogonal methods to distinguish surface-bound, internalized, degraded, and functionally delivered protein; compare constructs and define advancement criteria

• Establish fit-for-purpose neuronal culture models, including iPSC-derived neurons or glia where they add decision value, with appropriate banking and quality control

• Define assay controls, acceptance criteria, reproducibility standards, analysis plans, SOPs, sample tracking, and electronic documentation

• Translate data into concise recommendations to advance, modify, or discontinue assets

• Partner across protein engineering, chemistry, bioanalysis, DMPK, pathology, computational biology, and in vivo pharmacology; scientifically manage CROs and assay transfers

• Mentor junior scientists and build workflows that are reproducible across operators. Future scope may include ASO screening in partnership with external experts

Required Skills and Qualifications • PhD in pharmacology, neuroscience, molecular biology, chemical biology, cell biology, or a related discipline, plus 1 to 3 years of biotechnology or pharmaceutical industry experience

• Demonstrated experience in cellular pharmacology, assay development, and iterative drug discovery or lead optimization

• Hands-on experience with neuronal cell culture models, preferably human iPSC-derived neurons or glia

• Expertise in concentration-response, time-course, target-engagement, pharmacodynamic, quantitative data-analysis, and troubleshooting studies

• Concrete examples of scientific ownership in which an assay, platform, or data package influenced a program decision

• Excellent communication skills and willingness to maintain a substantial hands-on laboratory presence

Preferred Skills and Qualifications • Enzyme biology, epigenetics, or transcriptional pharmacology; therapeutic proteins or targeted-delivery constructs; cellular uptake, trafficking, or protein quantification; mitochondrial functional assays; high-content imaging or neuronal functional assays; transferrin receptor biology, BBB transport, or biodistribution; laboratory start-up, assay transfer, or CRO management

• Exposure to ASO screening or RNA pharmacology is beneficial

About LEXEO Lexeo Therapeutics is a New York City-based, clinical stage company dedicated to reshaping the path of genetic disease. By advancing pioneering science, Lexeo seeks to set a new standard in the treatment of cardiovascular and neurological genetic diseases, charting the path to patient outcomes once thought out of reach. The Company is advancing a portfolio of therapeutic candidates designed to address the underlying genetic causes of disease, including LX2006 for Friedreich ataxia (FA), LX2020 for plakophilin-2 (PKP2) arrhythmogenic cardiomyopathy, and others in devastating diseases with high unmet need. LEXEO Therapeutics is an EEO employer committed to an exciting, diverse, and enriching work environment.

Work location

  • New York, NY, US

Related jobs

Ready to make a decision?

This role is either worth your time or it isn’t.

Analyze the posting against your experience, see the gaps clearly, and build the right materials only if the opportunity makes sense.

Nothing is submitted automatically. You choose what happens next.

About this listing

Published on Lever under the board identifier Lexeotx, which is the name the employer’s own job board carries. RoleSprint has not verified the company’s registered or trading name, so it is shown exactly as published rather than tidied up.

RoleSprint is not the employer and not a recruiter. Applications are made on the employer’s own site and never reach us; what RoleSprint does is help you decide whether a role is worth your time and prepare for it if it is.

Published 13 October 2026, last checked 20 days ago. A posting stops being advertised here 90 days after the employer published it, and one the employer takes down is marked closed rather than quietly removed.

More searches like this one

Browse all current openings

No credit card requiredStart free